Almost every type of cancer can cause anemia, but some do it far more often — and more aggressively — than others. Hematologic cancers (leukemia, lymphoma, multiple myeloma) top the list because they directly invade the bone marrow where red blood cells are made. Close behind are colon cancer, kidney cancer, and gastric cancer, which cause anemia through chronic blood loss, reduced erythropoietin production, or both.
Studies show that roughly 30–90% of cancer patients develop anemia at some point during their illness, depending on cancer type and treatment stage. A landmark analysis published in the European Journal of Cancer found that anemia prevalence exceeded 60% in patients with lung, ovarian, and gynecologic cancers. So if you’ve been diagnosed with cancer and your hemoglobin is dropping, you’re far from alone — and there are concrete reasons why it’s happening.
Malignancy is only one pathway to a falling hemoglobin, and reviewing the broader causes of low blood counts helps clarify which factors are driving your particular case.
12 Cancers Most Likely to Cause Anemia
Not all cancers cause anemia through the same mechanism. Some destroy the marrow directly. Others bleed silently into the GI tract for months. Here’s a breakdown of the most common offenders and how they do it:
| Cancer Type | Estimated Anemia Prevalence | Primary Mechanism |
|---|---|---|
| Leukemia (AML, ALL, CLL) | Up to 90% | Direct bone marrow infiltration |
| Multiple Myeloma | 70–80% | Marrow replacement + kidney damage |
| Lymphoma (NHL, Hodgkin) | 40–70% | Marrow involvement + cytokine-driven inflammation |
| Colon/Colorectal Cancer | 50–60% | Chronic GI blood loss |
| Gastric Cancer | 50–60% | GI bleeding + impaired B12/iron absorption |
| Lung Cancer | 50–60% | Anemia of chronic disease + chemotherapy |
| Ovarian Cancer | 50–60% | Chronic disease + platinum-based chemo |
| Kidney (Renal Cell) Cancer | 30–50% | Reduced erythropoietin production + hematuria |
| Breast Cancer | 30–50% | Bone marrow metastasis + chemotherapy |
| Prostate Cancer | 25–50% | Bone metastasis + androgen deprivation therapy |
| Bladder Cancer | 30–40% | Chronic hematuria (blood in urine) |
| Pancreatic Cancer | 30–40% | Nutritional deficiency + chronic inflammation |
The 4 Ways Cancer Causes Anemia
There isn’t one single pathway — cancer attacks your red blood cell supply through multiple routes, often simultaneously.
1. Direct Bone Marrow Invasion
Leukemia cells and metastatic solid tumors physically crowd out the normal stem cells that produce red blood cells. Think of it as a hostile takeover of the factory floor. When marrow is more than 20–30% replaced by tumor, hemoglobin drops significantly.
2. Chronic Blood Loss
Colon, gastric, and bladder cancers frequently cause slow, ongoing bleeding that patients may not even notice. A right-sided colon tumor can bleed 2–6 mL per day — not enough to see in the stool, but enough to drain iron stores over weeks. This is why iron-deficiency anemia in anyone over 50 should always trigger a colonoscopy referral.
3. Anemia of Chronic Disease (ACD)
Tumors release inflammatory cytokines — particularly IL-6 and TNF-alpha — that trigger the liver to produce hepcidin. Hepcidin locks iron inside cells, making it unavailable for red blood cell production. Your lab work may show normal or even elevated ferritin levels while your body is functionally iron-starved. This is the most common mechanism in advanced solid tumors.
4. Treatment-Induced Myelosuppression
Chemotherapy (especially platinum-based agents like cisplatin and carboplatin) and radiation to large bone-bearing areas directly suppress marrow activity. Cisplatin also damages the kidneys, reducing erythropoietin production. Up to 75–90% of patients on platinum chemotherapy develop some degree of anemia.
How Cancer-Related Anemia Is Diagnosed
Doctors don’t just check a single hemoglobin number and call it a day. A proper workup includes several layers of testing to identify why the anemia is happening:
- Complete Blood Count (CBC): Hemoglobin below 12 g/dL in women or 13 g/dL in men confirms anemia. MCV (mean corpuscular volume) helps classify it as microcytic, normocytic, or macrocytic.
- Reticulocyte count: A low reticulocyte count suggests the marrow isn’t responding — pointing toward marrow infiltration or suppression rather than blood loss.
- Iron studies (ferritin, TIBC, serum iron): Distinguishes true iron deficiency (low ferritin, high TIBC) from anemia of chronic disease (normal/high ferritin, low TIBC).
- Peripheral blood smear: May show fragmented RBCs (schistocytes) in microangiopathic hemolysis, or tear-drop cells suggesting marrow infiltration.
- Bone marrow biopsy: The gold standard when marrow infiltration is suspected — essential in leukemia, myeloma, and myelodysplastic syndromes.
- Stool occult blood test / endoscopy: Critical for detecting GI blood loss in colorectal or gastric cancers.
Treatment Options
Treatment depends entirely on the mechanism driving the anemia. There’s no one-size-fits-all approach.
Red Blood Cell Transfusions
Transfusions provide the fastest relief and are typically used when hemoglobin drops below 7–8 g/dL or when symptoms are severe. Each unit of packed red blood cells raises hemoglobin by approximately 1 g/dL. The downside: iron overload, transfusion reactions, and alloimmunization with repeated use.
Erythropoiesis-Stimulating Agents (ESAs)
Drugs like epoetin alfa (Procrit) and darbepoetin alfa (Aranesp) stimulate the marrow to produce more red blood cells. They work best in chemotherapy-induced anemia when hemoglobin is below 10 g/dL. The FDA warns against using ESAs to target hemoglobin above 12 g/dL due to increased thromboembolic risk.
Iron Supplementation
Intravenous iron (ferric carboxymaltose, iron sucrose) is preferred over oral iron in cancer patients because inflammatory cytokines block gut absorption. IV iron paired with ESAs is more effective than either alone.
Treating the Underlying Cancer
Ultimately, the best treatment for cancer-related anemia is treating the cancer itself. Successful chemotherapy that achieves remission in leukemia, or surgical resection of a bleeding colon tumor, can resolve the anemia entirely.
When to See a Doctor
Don’t wait for symptoms to become debilitating. See your oncologist or primary care doctor promptly if you experience:
- Persistent fatigue that doesn’t improve with rest
- New or worsening shortness of breath during routine activities
- Heart racing at rest or with minimal exertion
- Black or tarry stools, or visible blood in urine
- Dizziness, lightheadedness, or near-fainting episodes
- Unexplained weight loss combined with pallor
If you haven’t been diagnosed with cancer but have unexplained iron-deficiency anemia — especially if you’re over 50 — insist on a colonoscopy and upper endoscopy. Occult GI malignancy is one of the most common causes of unexplained iron-deficiency anemia in this age group.
Frequently Asked Questions
Can anemia be the first sign of cancer?
Yes, and this is more common than many people realize. Iron-deficiency anemia is the presenting symptom in up to 11% of colorectal cancer cases. Persistent, unexplained anemia — especially in men or postmenopausal women — warrants investigation for an underlying malignancy.
What hemoglobin level is dangerous for cancer patients?
Most oncologists become concerned when hemoglobin falls below 8 g/dL. Below 7 g/dL, transfusion is usually required because the body can’t compensate adequately for the reduced oxygen-carrying capacity. However, symptomatic patients may need intervention at higher levels.
Does anemia mean my cancer is getting worse?
Not necessarily. Anemia during chemotherapy is extremely common and often expected. However, worsening anemia in someone not on treatment — or anemia that doesn’t recover between chemo cycles — can indicate disease progression or marrow involvement and should be investigated.
Can you die from cancer-related anemia?
Severe anemia (hemoglobin below 5–6 g/dL) can be life-threatening, causing heart failure and organ damage. However, death from anemia alone is uncommon in patients receiving active medical care. The greater concern is that chronic anemia worsens overall prognosis and reduces tolerance to cancer treatment.
Will my anemia go away after cancer treatment ends?
In many cases, yes. Chemotherapy-induced anemia typically resolves within 2–3 months after completing treatment as bone marrow recovers. Anemia from chronic blood loss resolves once the bleeding source is removed. However, some patients — particularly those who received platinum-based regimens — may experience prolonged marrow recovery.
